Overview of Dr. Koprivnikar
Dr. Jamie Koprivnikar is an oncologist in Hackensack, NJ and is affiliated with multiple hospitals in the area, including Hackensack Meridian Health Hackensack University Medical Center and Hackensack Meridian Health Jersey Shore University Medical Center. She received her medical degree from Sidney Kimmel Medical College at Thomas Jefferson University and has been in practice 16 years. She is one of 130 doctors at Hackensack Meridian Health Hackensack University Medical Center and one of 41 doctors at Hackensack Meridian Health Jersey Shore University Medical Center who specialize in Oncology. She has more than 10 publications and over 100 citings.
Office
92 2nd Street
Hackensack, NJ 07601- Is this information wrong?
Education & Training
MedStar Health/Georgetown University HospitalFellowship, Hematology and Medical Oncology, 2009 - 2012- MedStar Health/Georgetown University HospitalResidency, Internal Medicine, 2006 - 2009
Sidney Kimmel Medical College at Thomas Jefferson UniversityClass of 2006
Certifications & Licensure
NJ State Medical License 2015 - 2025
MD State Medical License 2012 - 2016
DC State Medical License 2006 - 2016
VA State Medical License 2006 - 2014- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Single Agent and Combined Inhibition After Allogeneic Stem Cell Transplant Start of enrollment: 2019 Mar 08
- Study of Efficacy of CML-CP Patients Treated With ABL001 Versus Bosutinib, Previously Treated With 2 or More TKIs Start of enrollment: 2017 Oct 26
- Study of Crenolanib vs Midostaurin Following Induction Chemotherapy and Consolidation Therapy in Newly Diagnosed FLT3 Mutated AML Start of enrollment: 2018 Aug 15
- Join now to see all
Publications & Presentations
PubMed
- CPX-351 Pharmacokinetics and Safety in Adults with Hematologic Malignancies and Renal Function Impairment: Phase 1 Trial.Scott R Solomon, Bayard L Powell, Jamie Koprivnikar, Catherine Lai, Heather Male, Laura C Michaelis, Laura F Newell, David Sanford, Jack Jenkins, Amy Zelaya, Sheryl Co...> ;Cancers. 2024 Feb 24
- Aspacytarabine for the treatment of patients with AML unfit for intensive chemotherapy: a phase 2 study.Altman, J., Zuckerman, T., Koprivnikar, J., McCloskey, J., Kota, V., Keng, M., Frankfurt, O., Abaza, Y., Bixby, D., Emadi, A., Burch, M., Bhatnagar, B., Luger, S., Per...> ;Blood Advances. 2023 Dec 26
- Injection Site Reactions with Long-Term Pegcetacoplan Use in Patients with Paroxysmal Nocturnal Hemoglobinuria: A Brief Report.Vivek Sharma, Jamie Koprivnikar, Kristen Drago, Jessica Savage, Allison Bachelor> ;Advances in Therapy. 2023 Nov 1
- Join now to see all
Abstracts/Posters
- Combined Venetoclax and Hypomethylating Agent (HMA) Therapy Induces High Response Rates in Patients with Myelodysplastic Syndrome Including Patients Previously Failing...Jamie Koprivnikar, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Blinatumomab in Combination with Tyrosine Kinase Inhibitors Safely and Effectively Induces Rapid, Deep, and Durable Molecular Responses in Relapsed and Refractory Phil...Jamie Koprivnikar, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Pharmacodynamic Responses to CC-90009, a Novel Cereblon E3 Ligase Modulator, in a Phase I Dose-Escalation Study in Relapsed or Refractory Acute Myeloid Leukemia (R/R AML)Jamie Koprivnikar, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Lectures
- Molecular Epidemiologic Associations in Acute Myeloid Leukemia (AML) and Myelodysplastic Syndromes (MDS) within the United States2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Survival Differences Among Patients (pts) with Acute Myeloid Leukemia (AML) Treated with Allogeneic Hematopoietic Cell Transplantation (HCT) Versus Non-HCT Therapies: ...2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Limitations to Receiving Allogeneic Hematopoietic Cell Transplantation for Treatment of Acute Myeloid Leukemia: A Large Multi-Center Prospective Longitudinal Observati...2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
Hospital Affiliations
Hackensack Meridian Health Hackensack University Medical CenterHackensack, New Jersey
Hackensack Meridian Health Jersey Shore University Medical CenterNeptune, New Jersey
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
